Condition
WHO Grade 2 Glioma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 WHO Grade 2 Glioma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Canada (1), Puerto Rico (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Treatment of recurrent high-grade gliomas using anti-GARP CAR T cell therapy
This study is testing a new type of CAR T cell therapy to see if it can safely help people with recurring high-grade gliomas fight their tumors better.
-
Comparing selumetinib to standard chemotherapy for low-grade glioma
This study is testing if a new drug called selumetinib can help people with low-grade glioma live longer without their cancer getting worse compared to the usual chemotherapy.
Related topics
Quick answers
How many WHO Grade 2 Glioma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Canada (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.